HOME | ABOUT US | MEDIA KIT | CONTACT US | INQUIRE
Health IT giant Cerner plans to acquire the health division of London-based Kantar Group for $375 million.
The buy is expected to advance clinical research development. Kantar Health provides data, analytics, and research to the life sciences industry.
With this acquisition, Cerner plans to harness data to improve the safety, efficiency and efficacy of clinical research across life sciences, pharmaceuticals and health care at large, the company said in a news release.
Kantar Health has over $150 million of annual revenue, according to Cerner.
“Cerner launched the Learning Health Network with our provider clients to advance a shared vision: treat global diseases more effectively through an acceleration of clinical research,” Cerner Presient Donald Trigg said. “Kantar Health has incredible health economics and medical affairs expertise, differentiated real-world data assets and strong relationships with the world’s leading life science companies. It offers us an amazing opportunity to drive cross-industry collaboration that can change health outcomes around the world.”
The combination of Cerner and Kantar Health is expected to enable a two-sided collaboration between providers and the pharmaceutical industry, where researchers can generate insights and use differentiated real-world data assets and expertise to address the most complex clinical research questions.